JP2003527342A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003527342A5 JP2003527342A5 JP2001539455A JP2001539455A JP2003527342A5 JP 2003527342 A5 JP2003527342 A5 JP 2003527342A5 JP 2001539455 A JP2001539455 A JP 2001539455A JP 2001539455 A JP2001539455 A JP 2001539455A JP 2003527342 A5 JP2003527342 A5 JP 2003527342A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- glucocorticoid receptor
- receptor antagonist
- administration
- amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16743299P | 1999-11-23 | 1999-11-23 | |
| US60/167,432 | 1999-11-23 | ||
| PCT/US2000/032260 WO2001037840A1 (en) | 1999-11-23 | 2000-11-21 | Methods for treating mild cognitive impairment |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003527342A JP2003527342A (ja) | 2003-09-16 |
| JP2003527342A5 true JP2003527342A5 (cg-RX-API-DMAC7.html) | 2007-11-29 |
Family
ID=22607362
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001539455A Pending JP2003527342A (ja) | 1999-11-23 | 2000-11-21 | 軽度認知障害を処置する方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US6620802B1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1242094A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2003527342A (cg-RX-API-DMAC7.html) |
| AU (1) | AU778090B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2389570C (cg-RX-API-DMAC7.html) |
| HK (1) | HK1047050A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2001037840A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20010046470A1 (en) * | 2000-05-10 | 2001-11-29 | Kieko Morita | Diagnoses and treatment of disorders using an alternative glucose pathway |
| NZ528147A (en) | 2001-03-23 | 2005-06-24 | Corcept Therapeutics Inc | Methods for treating stress disorders using glucocorticoid receptor-specific antagonists |
| MXPA04001893A (es) * | 2001-08-31 | 2005-03-07 | Corcept Therapeutics Inc | Metodos para inhibir deterioro cognoscitivo en adultos con sindrome de down. |
| AU2003217046A1 (en) * | 2002-04-05 | 2003-10-27 | The University Of Edinburgh | Pharmaceutical compositions comprising a 11-beta hydroxysteroid dehydrogenase inhibitor and a diuretic agent |
| US8237946B2 (en) * | 2004-10-08 | 2012-08-07 | Sharp Laboratories Of America, Inc. | Methods and systems for imaging device accounting server redundancy |
| US20090156565A1 (en) * | 2004-12-03 | 2009-06-18 | The Children's Hospital Of Philadelphia | Composition and use thereof in enhancing a therapeutic effect of an antiepileptic drug |
| EA033130B1 (ru) * | 2008-10-16 | 2019-08-30 | Дзе Джонс Хопкинс Юниверсити | Способы и композиции для улучшения когнитивной функции |
| US20110202284A1 (en) * | 2010-02-10 | 2011-08-18 | Mcreynolds Cristopher | Novel groups of biomarkers for diagnosing alzheimer's disease |
| US10500216B2 (en) | 2011-11-18 | 2019-12-10 | Corcept Therapeutics, Inc. | Optimizing mifepristone absorption |
| WO2014074744A1 (en) * | 2012-11-09 | 2014-05-15 | Lasser Elliott C | X-ray contrast media compositions and methods of using the same to treat inflammation associated conditions |
| US20140206667A1 (en) | 2012-11-14 | 2014-07-24 | Michela Gallagher | Methods and compositions for treating schizophrenia |
| AU2014228512A1 (en) | 2013-03-15 | 2015-10-01 | Agenebio, Inc. | Methods and compositions for improving cognitive function |
| US10806717B2 (en) | 2013-03-15 | 2020-10-20 | The Johns Hopkins University | Methods and compositions for improving cognitive function |
| US9943526B2 (en) | 2015-04-21 | 2018-04-17 | Corcept Therapeutics, Inc. | Optimizing mifepristone levels for cushing's patients |
| WO2016191288A1 (en) | 2015-05-22 | 2016-12-01 | Agenebio, Inc. | Extended release pharmaceutical compositions of levetiracetam |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3337450A1 (de) * | 1983-10-12 | 1985-04-25 | Schering AG, 1000 Berlin und 4709 Bergkamen | Prostaglandine und antigestagene fuer den schwangerschaftsabbruch |
| ATE363908T1 (de) | 1996-04-09 | 2007-06-15 | Univ Edinburgh | Verwendung von 7-alpha-substituierten steroiden zur behandlung von neuropsychiatrischen erkrankungen |
| ES2268792T3 (es) | 1997-10-06 | 2007-03-16 | The Board Of Trustees Of The Leland Stanford Junior University | Metodos para el tratamiento de la psicosis asociada cuya patogenesis esta relacionada con la disfuncion de la via reguladora de clucocorticoides. |
| JP2003505336A (ja) | 1998-05-15 | 2003-02-12 | ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティ | 痴呆の処置のためのグルココルチコイドレセプターアンタゴニスト |
-
2000
- 2000-11-20 US US09/717,703 patent/US6620802B1/en not_active Expired - Lifetime
- 2000-11-21 JP JP2001539455A patent/JP2003527342A/ja active Pending
- 2000-11-21 AU AU19283/01A patent/AU778090B2/en not_active Expired
- 2000-11-21 EP EP00982226A patent/EP1242094A4/en not_active Ceased
- 2000-11-21 WO PCT/US2000/032260 patent/WO2001037840A1/en not_active Ceased
- 2000-11-21 CA CA2389570A patent/CA2389570C/en not_active Expired - Lifetime
- 2000-11-21 HK HK02108738.8A patent/HK1047050A1/zh unknown
-
2003
- 2003-07-28 US US10/628,724 patent/US20040019028A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2003527342A5 (cg-RX-API-DMAC7.html) | ||
| EP1023074B1 (en) | Methods for treating psychosis associated with glucocorticoid related dysfunction | |
| JP2003505336A5 (cg-RX-API-DMAC7.html) | ||
| Haria et al. | Loratadine: a reappraisal of its pharmacological properties and therapeutic use in allergic disorders | |
| JP2001518509A5 (cg-RX-API-DMAC7.html) | ||
| AU726091B2 (en) | Monophasic contraceptive method and kit comprising a combination of a progestin and estrogen | |
| US5747480A (en) | Oral contraceptive | |
| CA2440605A1 (en) | Methods for treating stress disorders using glucocorticoid receptor-specific antagonists | |
| CA2389570A1 (en) | Methods for treating mild cognitive impairment | |
| CA2454339A1 (en) | Methods for preventing antipsychotic-induced weight gain | |
| JP2006508951A5 (cg-RX-API-DMAC7.html) | ||
| CA2504697A1 (en) | Methods for treating migraine | |
| JP2006507311A5 (cg-RX-API-DMAC7.html) | ||
| JP2005535664A5 (cg-RX-API-DMAC7.html) | ||
| JP2008500340A (ja) | 月経前不機嫌性障害の処置のための組成物および方法 | |
| CA2459033A1 (en) | Methods for inhibiting cognitive deterioration in adults with down's syndrome | |
| EP0917466B1 (en) | Oral contraceptive | |
| US6451778B1 (en) | Oral contraceptive | |
| JPH07278017A (ja) | 麻薬又は麻薬混合物からの自然の又は早められた退薬症状と関連した徴候を予防し又は治療するための薬剤の製造への抗グルココルチコイド活性を有する化合物の使用及びそれらを含有する組成物 | |
| EP0921804B1 (en) | Biphasic oral contraceptive method and kit comprising a combination of a progestin and estrogen | |
| CA2561839C (en) | Multi-phase contraceptive preparation based on a natural estrogen | |
| Baulieu | A novel approach to human fertility control: contragestion by the anti-progesterone RU 486 | |
| Guarderas | Rhinitis and sinusitis: office management | |
| JP2005512949A5 (cg-RX-API-DMAC7.html) | ||
| CA2532594A1 (en) | Antiglucocorticoids for the treatment of catatonia |